拯救脓毒症运动:2021年脓毒症与脓毒性休克管理国际指南的解读与展望
2021年拯救脓毒症运动国际指南基于截至2019年7月的文献,分为筛查与早期治疗、感染、血流动力学管理、通气、附加治疗、长期结局与照护目标6部分,共93个条目、99条推荐。与2016年指南(96条推荐)相比,推荐总数相近,但强推荐(推荐)数量显著下降、弱推荐(建议)显著增加,推荐所依据的证据质量显著降低。2021年指南明显删除或简化了感染预防、急性呼吸窘迫综合征(ARDS)治疗、营养支持等推荐,最明显的改进在长期结局与照护目标部分。指南未采纳mNGS、膈肌保护性通气、急性肾损伤启动肾脏替代治疗的时机、早期活动、内毒素吸附、氨甲环酸、电子医学与远程医疗、大数据与人工智能等新兴治疗。总体提示2021年指南趋于保守和简化,而非优化和逻辑化,未来可能引发争议并影响临床医生依从性。
要点
- 2021年指南共6部分93个条目99条推荐,证据检索截至2019年7月。
- 与2016年指南96条推荐相比,2021年强推荐(推荐)显著减少、弱推荐(建议)显著增加。
- 2021年推荐所依据的证据质量显著降低。
- 2021年指南明显删除或简化了感染预防、ARDS治疗、营养支持等推荐。
- 长期结局与照护目标是2021年指南最明显的改进部分,帮助患者及家属确定康复和出院随访计划并制定确切照护目标。
研究设计与关键结果
- 2021年指南基于截至2019年7月的文献证据,分为筛查与早期治疗、感染、血流动力学管理、通气、附加治疗、长期结局与照护目标6部分,共93个条目、99条推荐。
- 与2016年指南(96条推荐)相比,2021年指南强推荐(推荐)数量显著下降,弱推荐(建议)数量显著增加,推荐所依据的证据质量显著降低。
- 2021年指南明显删除或简化了感染预防、急性呼吸窘迫综合征(ARDS)治疗、营养支持等推荐。
- 长期结局与照护目标部分是2021年指南最明显的改进,患者及家属可在确定身体康复和出院随访计划、制定确切照护目标方面获得帮助。
- 2021年指南未采纳mNGS、膈肌保护性通气、急性肾损伤启动肾脏替代治疗的时机、早期活动、内毒素吸附、氨甲环酸、电子医学与远程医疗、大数据与人工智能等新兴疗法或治疗。
证据类型、等级与局限
- 证据类型:指南解读。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为2021年指南趋于保守和简化,而非优化和逻辑化,未来可能引发争议并影响临床医生依从性。
指南或共识出处
- 拯救脓毒症运动:2021年脓毒症与脓毒性休克管理国际指南
提炼说明
- 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
The Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021 (2021 guidelines) was recently released. The guidelines summarized the evidences from literatures up to July 2019, and composed by 6 parts as "screening and early treatment", "infection", "hemodynamic management", "ventilation", "additional therapies" and "long-term outcomes and goals of care" with a total of 93 items and 99 recommendations. Compared with the 2016 guidelines (96 recommendations), although the total number of recommendations in the 2021 guidelines is similar, the number of "strong recommendations (recommend)" in 2021 guidelines has dropped significantly, as the number of "weak recommendations (suggest)" has increased significantly, and the level of the quality of evidence on which the recommendations are based has been significantly lowered. Furthermore, 2021 guidelines have also markedly deleted or simplified the recommendations regarding infection prevention, acute respiratory distress syndrome (ARDS) treatment, nutritional support and so on. While, the most obvious improvement appears in the segment of "long-term outcomes and goals of care", in which the patients and their families could get help in term of determining their physical rehabilitation and discharge follow-up plans and formulating exact goals of care. 2021 guidelines did not adopt new and emerging therapies or treatments, such as metagenomic next-generation sequencing (mNGS), diaphragm protective ventilation, timing of initiating renal replacement therapy for acute kidney injury, early mobility, endotoxin adsorption, tranexamic acid, E-medicine and telemedicine, big data and artificial intelligence and other new therapies. Collectively, it may suggest the 2021 guidelines tend to be conservative and simplified rather than fairly optimized and logicalized, which may arouse controversy in the future and affect clinician compliance.
参考来源
- Zheng R, Zhang Y, Rong Z, et al. [Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021, interpretation and expectation]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34955122. doi:10.3760/cma.j.cn121430-20211009-01442
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。